NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for January 20121. Trading volumes declined year-over-year across most venues, but generally rebounded from seasonally slower December 2011. Global derivatives average daily volume (“ADV”) of 7.5 million contracts in January 2012 decreased 17.3% versus the prior year, with European Derivatives declining 31.3% and U.S. equity options decreasing 4.1%. European cash trading ADV decreased 14.6% and U.S. cash trading ADV decreased 23.5% from January 2011 levels. Highlights Derivatives Trading European Derivatives U.S. Derivatives Cash Trading European Cash U.S. Cash Exchange Traded Funds Please click here for the Monthly Transaction Activity Data Table. About NYSE Euronext NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets – the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca – represent one-third of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the Fortune 500. For more information, please visit: http://www.nyx.com. Disclaimer and Cautionary Note Regarding Forward-Looking Statements This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext's plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext's results to differ materially from current expectations include, but are not limited to: NYSE Euronext's ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext's reference document for 2010 ("document de référence") filed with the French Autorité des Marchés Financiers (Filed on April 19, 2011 under No. D.11-0333), 2010 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorité des Marchés Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein. 1 All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. NYSE Euronext European equities transactions count each buy and sell order as separate transactions, NYSE Euronext U.S. equities transactions count buy and sell orders together as a single transaction.
NYSE Euronext |
||||||||||||||||||||||||
Monthly Volume Summary |
||||||||||||||||||||||||
Average Daily Volume | Total Volume | Average Daily Volume | Total Volume | |||||||||||||||||||||
(Unaudited; contracts in thousands) |
Jan-12 |
Jan-11 |
% Chg |
Jan-12 |
Jan-11 |
% Chg |
YTD 2011 |
% Chg vs. |
YTD 2011 |
% Chg vs. |
||||||||||||||
Number of Trading Days - European Markets | 22 | 21 | 22 | 21 | 22 | 22 | ||||||||||||||||||
Number of Trading Days - U.S. Markets | 20 | 20 | 20 | 20 | 20 | 20 | ||||||||||||||||||
European Derivatives Products | 3,222 | 4,688 | -31.3% | 70,891 | 98,441 | -28.0% | 3,222 | -31.3% | 70,891 | -28.0% | ||||||||||||||
of which Bclear | 546 | 954 | -42.8% | 12,014 | 20,044 | -40.1% | 546 | -42.8% | 12,014 | -40.1% | ||||||||||||||
Total Fixed Income Products | 1,842 | 2,622 | -29.7% | 40,529 | 55,060 | -26.4% | 1,842 | -29.7% | 40,529 | -26.4% | ||||||||||||||
Short Term Interest Rate Products | 1,723 | 2,515 | -31.5% | 37,904 | 52,825 | -28.2% | 1,723 | -31.5% | 37,904 | -28.2% | ||||||||||||||
Medium and Long Term Interest Rate Products 1 | 119 | 106 | 12.1% | 2,625 | 2,234 | 17.5% | 119 | 12.1% | 2,625 | 17.5% | ||||||||||||||
Total Equity Products 2 | 1,305 | 1,991 | -34.5% | 28,711 | 41,821 | -31.3% | 1,305 | -34.5% | 28,711 | -31.3% | ||||||||||||||
Individual Equity Products | 906 | 1,470 | -38.3% | 19,936 | 30,863 | -35.4% | 906 | -38.3% | 19,936 | -35.4% | ||||||||||||||
Futures | 402 | 750 | -46.5% | 8,837 | 15,753 | -43.9% | 402 | -46.5% | 8,837 | -43.9% | ||||||||||||||
Options | 504 | 720 | -29.9% | 11,099 | 15,110 | -26.5% | 504 | -29.9% | 11,099 | -26.5% | ||||||||||||||
Equity Index Products | 399 | 522 | -23.6% | 8,775 | 10,958 | -19.9% | 399 | -23.6% | 8,775 | -19.9% | ||||||||||||||
of which Bclear | 546 | 954 | -42.8% | 12,014 | 20,044 | -40.1% | 546 | -42.8% | 12,014 | -40.1% | ||||||||||||||
Individual Equity Products | 486 | 887 | -45.1% | 10,701 | 18,617 | -42.5% | 486 | -45.1% | 10,701 | -42.5% | ||||||||||||||
Futures | 402 | 750 | -46.4% | 8,837 | 15,747 | -43.9% | 402 | -46.4% | 8,837 | -43.9% | ||||||||||||||
Options | 85 | 137 | -38.0% | 1,865 | 2,870 | -35.0% | 85 | -38.0% | 1,865 | -35.0% | ||||||||||||||
Equity Index Products | 60 | 68 | -12.2% | 1,312 | 1,427 | -8.0% | 60 | -12.2% | 1,312 | -8.0% | ||||||||||||||
Commodity Products | 75 | 74 | 1.0% | 1,651 | 1,560 | 5.8% | 75 | 1.0% | 1,651 | 5.8% | ||||||||||||||
U.S. Derivatives Products | ||||||||||||||||||||||||
Equity Options 3 | ||||||||||||||||||||||||
NYSE Euronext Options Contracts | 4,171 | 4,350 | -4.1% | 83,425 | 86,998 | -4.1% | 4,171 | -4.1% | 83,425 | -4.1% | ||||||||||||||
Total Consolidated Options Contracts | 15,668 | 17,740 | -11.7% | 313,363 | 354,796 | -11.7% | 15,668 | -11.7% | 313,363 | -11.7% | ||||||||||||||
NYSE Group Share of Total | 26.6% | 24.5% | 26.6% | 24.5% | 26.6% | 2.1% | 26.6% | 2.1% | ||||||||||||||||
NYSE Liffe U.S. | ||||||||||||||||||||||||
Futures and Futures Options Volume* | 94.9 | 13.5 | 603.1% | 1,993 | 283 | 603.1% | 94.9 | 603.1% | 1,992.7 | 603.1% | ||||||||||||||
European Cash Products (trades in thousands) | 1,510 | 1,768 | -14.6% | 33,222 | 37,138 | -10.5% | 1,510 | -14.6% | 33,222 | -10.5% | ||||||||||||||
Equities | 1,455 | 1,699 | -14.3% | 32,020 | 35,677 | -10.2% | 1,455 | -14.3% | 32,020 | -10.2% | ||||||||||||||
Exchange-Traded Funds | 15 | 20 | -24.0% | 341 | 428 | -20.4% | 15 | -24.0% | 341 | -20.4% | ||||||||||||||
Structured Products | 35 | 44 | -21.0% | 760 | 919 | -17.3% | 35 | -21.0% | 760 | -17.3% | ||||||||||||||
Bonds | 5 | 5 | -15.1% | 101 | 114 | -11.0% | 5 | -15.1% | 101 | -11.0% | ||||||||||||||
U.S. Cash Products (shares in millions) 5 | 1,814 | 2,372 | -23.5% | 36,276 | 47,442 | -23.5% | 1,814 | -23.5% | 36,276 | -23.5% | ||||||||||||||
NYSE Listed (Tape A) Issues 4 | ||||||||||||||||||||||||
Handled Volume 5 | 1,291 | 1,740 | -25.8% | 25,825 | 34,796 | -25.8% | 1,291 | -25.8% | 25,825 | -25.8% | ||||||||||||||
Matched Volume 6 | 1,217 | 1,644 | -25.9% | 24,346 | 32,872 | -25.9% | 1,217 | -25.9% | 24,346 | -25.9% | ||||||||||||||
Total NYSE Listed Consolidated Volume | 4,014 | 4,849 | -17.2% | 80,286 | 96,985 | -17.2% | 4,014 | -17.2% | 80,286 | -17.2% | ||||||||||||||
Share of Total Consolidated Volume | ||||||||||||||||||||||||
Handled Volume 5 | 32.2% | 35.9% | -3.7% | 32.2% | 35.9% | -3.7% | 32.2% | -3.7% | 32.2% | -3.7% | ||||||||||||||
Matched Volume 6 | 30.3% | 33.9% | -3.6% | 30.3% | 33.9% | -3.6% | 30.3% | -3.6% | 30.3% | -3.6% | ||||||||||||||
NYSE Arca & Amex (Tape B) Listed Issues | ||||||||||||||||||||||||
Handled Volume 5 | 272 | 332 | -18.3% | 5,433 | 6,648 | -18.3% | 272 | -18.3% | 5,433 | -18.3% | ||||||||||||||
Matched Volume 6 | 242 | 298 | -18.7% | 4,850 | 5,968 | -18.7% | 242 | -18.7% | 4,850 | -18.7% | ||||||||||||||
Total NYSE Arca & Amex Listed Consolidated Volume | 1,114 | 1,288 | -13.5% | 22,272 | 25,753 | -13.5% | 1,114 | -13.5% | 22,272 | -13.5% | ||||||||||||||
Share of Total Consolidated Volume | ||||||||||||||||||||||||
Handled Volume 5 | 24.4% | 25.8% | -1.4% | 24.4% | 25.8% | -1.4% | 24.4% | -1.4% | 24.4% | -1.4% | ||||||||||||||
Matched Volume 6 | 21.8% | 23.2% | -1.4% | 21.8% | 23.2% | -1.4% | 21.8% | -1.4% | 21.8% | -1.4% | ||||||||||||||
Nasdaq Listed (Tape C) Issues | ||||||||||||||||||||||||
Handled Volume 5 | 251 | 300 | -16.3% | 5,018 | 5,997 | -16.3% | 251 | -16.3% | 5,018 | -16.3% | ||||||||||||||
Matched Volume 6 | 214 | 255 | -16.1% | 4,279 | 5,098 | -16.1% | 214 | -16.1% | 4,279 | -16.1% | ||||||||||||||
Total Nasdaq Listed Consolidated Volume | 1,818 | 2,044 | -11.1% | 36,355 | 40,882 | -11.1% | 1,818 | -11.1% | 36,355 | -11.1% | ||||||||||||||
Share of Total Consolidated Volume | ||||||||||||||||||||||||
Handled Volume 5 | 13.8% | 14.7% | -0.9% | 13.8% | 14.7% | -0.9% | 13.8% | -0.9% | 13.8% | -0.9% | ||||||||||||||
Matched Volume 6 | 11.8% | 12.5% | -0.7% | 11.8% | 12.5% | -0.7% | 11.8% | -0.7% | 11.8% | -0.7% | ||||||||||||||
Exchange-Traded Funds 5,7 | ||||||||||||||||||||||||
Handled Volume 5 | 256 | 300 | -14.7% | 5,116 | 5,996 | -14.7% | 256 | -14.7% | 5,116 | -14.7% | ||||||||||||||
Matched Volume 6 | 228 | 270 | -15.6% | 4,556 | 5,396 | -15.6% | 228 | -15.6% | 4,556 | -15.6% | ||||||||||||||
Total ETF Consolidated Volume | 1,074 | 1,175 | -8.7% | 21,470 | 23,507 | -8.7% | 1,074 | -8.7% | 21,470 | -8.7% | ||||||||||||||
Share of Total Consolidated Volume | ||||||||||||||||||||||||
Handled Volume 5 | 23.8% | 25.5% | -1.7% | 23.8% | 25.5% | -1.7% | 23.8% | -1.7% | 23.8% | -1.7% | ||||||||||||||
Matched Volume 6 | 21.2% | 23.0% | -1.8% | 21.2% | 23.0% | -1.8% | 21.2% | -1.8% | 21.2% | -1.8% |
1 | Data includes currency products. | |
2 |
Includes all trading activities for Bclear, NYSE Liffe's clearing service for wholesale derivatives. | |
3 | Includes trading in U.S. equity options contracts, not equity-index options. | |
4 | Includes all volume executed in NYSE Group crossing sessions. | |
5 | Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots. | |
6 | Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges. | |
7 | Data included in previously identified categories. | |
* | ADVs calculated with the appropriate number of NYSE Liffe U.S. trading days. | |
Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities. | ||
All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells. |